Juan Li
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Juan Li has a total of 33 co-authors. Here are the top co-authors by number of shared publications:
- Shunxiang Li
School of Pharmacy, Hunan University of Chinese Medicine
5 shared publications - Yan Duan
School of Pharmacy, Hunan University of Chinese Medicine, Changsha, Hunan, 410208, China; Hunan Engineering Technology Research Center for Bioactive Substance Discovery of Chinese Medicine, Changsha, Hunan, 410208, China; Hunan Province Sino-US International Joint Research Center for Therapeutic Drugs of Senile Degenerative Diseases, Changsha, Hunan, 410208, China
3 shared publications - Chen-Hui Li
Hunan Province Engineering Research Center of Bioactive Substance Discovery of Chinese Medicine, School of Pharmacy, Hunan University of Chinese Medicine, Changsha, Hunan 410208, P. R. China
1 shared publication Guannan Xue
School of Pharmacy, Hunan University of Chinese Medicine
1 shared publicationGuo-Ping Liu
Hainan Xiangning Industrial Co., Ltd, Danzhou, Hainan 571924, P. R. China
1 shared publication- Jianping Kong
School of Pharmacy, China Pharmaceutical University, Nanjing 210009, China
1 shared publication
Latest Publications
- Open Access
- 20 October 2026
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 17, 1942636
Treatment of vascular dementia based on neuroprotection and neural repair strategies: from pathophysiology to natural products
Vascular dementia (VaD) is a heterogeneous cognitive disorder associated with cerebrovascular pathology and persistent vascular dysfunction. Because effective disease-modifying therapies remain limited, natural products have attracted interest as potential interventions for the complex pathology of VaD. This review examines their effects from two complementary perspectives: neuroprotection and neural repair. Experimental studies indicate that natural products can influence several interconnected processes, including redox imbalance, neuroinflammation, cell survival, blood–brain barrier dysfunction, vascular remodeling, neurogenesis, and synaptic plasticity. However, the available evidence varies considerably among isolated compounds, botanical extracts, and herbal formulations. Some isolated compounds have been supported by relatively coherent relationships between molecular targets, tissue responses, and functional outcomes, whereas evidence from clinical studies remains much more limited. We therefore consider the current mechanistic evidence together with the major challenges in pharmacokinetics, quality control, and clinical translation.
- 20 October 2026
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 17, 1942636
Open AccessTreatment of vascular dementia based on neuroprotection and neural repair strategies: from pathophysiology to natural products
Vascular dementia (VaD) is a heterogeneous cognitive disorder associated with cerebrovascular pathology and persistent vascular dysfunction. Because effective disease-modifying therapies remain limited, natural products have attracted interest as potential interventions for the complex pathology of VaD. This review examines their effects from two complementary perspectives: neuroprotection and neural repair. Experimental studies indicate that natural products can influence several interconnected processes, including redox imbalance, neuroinflammation, cell survival, blood–brain barrier dysfunction, vascular remodeling, neurogenesis, and synaptic plasticity. However, the available evidence varies considerably among isolated compounds, botanical extracts, and herbal formulations. Some isolated compounds have been supported by relatively coherent relationships between molecular targets, tissue responses, and functional outcomes, whereas evidence from clinical studies remains much more limited. We therefore consider the current mechanistic evidence together with the major challenges in pharmacokinetics, quality control, and clinical translation.
- Open Access
- 1 January 2026
- Published by Maximum Academic Press in Targetome
- Vol. 2 (4)
Immunosenescence-driven bone marrow immune niche destabilization in osteoporosis: microenvironmental targets and natural product-mediated reprogramming
Osteoporosis is a heterogeneous skeletal disorder arising from diverse age-related, endocrine, metabolic, mechanical, and pharmacological factors. In age-related, postmenopausal, and selected metabolism-associated forms of osteoporosis, immunosenescence may contribute to dysfunction in the bone marrow immune niche, thereby amplifying bone resorption and regenerative decline. This review examines osteoporosis through the complementary perspective of the bone marrow immune niche and summarizes the core mechanisms by which immunosenescence contributes to destabilization of the bone marrow immune niche in osteoporosis. On this basis, we further discuss the molecular basis and regulatory potential of natural products in mediating bone marrow-related immune microenvironmental reprogramming. Emerging technologies, including single-cell omics, spatial omics, organoid models, and humanized research platforms, are also integrated to propose novel strategies for the precision prevention and treatment of osteoporosis. Overall, this review incorporates immune microenvironmental regulation into the conventional framework of bone metabolic dysfunction and provides a systematic theoretical basis for mechanistic elucidation, precision delivery, and clinical translation of natural products in prevention and treatment of osteoporosis.
- 1 January 2026
- Published by Maximum Academic Press in Targetome
- Vol. 2 (4)
Open AccessImmunosenescence-driven bone marrow immune niche destabilization in osteoporosis: microenvironmental targets and natural product-mediated reprogramming
Osteoporosis is a heterogeneous skeletal disorder arising from diverse age-related, endocrine, metabolic, mechanical, and pharmacological factors. In age-related, postmenopausal, and selected metabolism-associated forms of osteoporosis, immunosenescence may contribute to dysfunction in the bone marrow immune niche, thereby amplifying bone resorption and regenerative decline. This review examines osteoporosis through the complementary perspective of the bone marrow immune niche and summarizes the core mechanisms by which immunosenescence contributes to destabilization of the bone marrow immune niche in osteoporosis. On this basis, we further discuss the molecular basis and regulatory potential of natural products in mediating bone marrow-related immune microenvironmental reprogramming. Emerging technologies, including single-cell omics, spatial omics, organoid models, and humanized research platforms, are also integrated to propose novel strategies for the precision prevention and treatment of osteoporosis. Overall, this review incorporates immune microenvironmental regulation into the conventional framework of bone metabolic dysfunction and provides a systematic theoretical basis for mechanistic elucidation, precision delivery, and clinical translation of natural products in prevention and treatment of osteoporosis.
- 8 December 2025
- Published by Royal Society of Chemistry (RSC) in Food & Function
- Vol. 16 (24) , 9300-9343
Morinda citrifolia L. (noni) and its potential in the management of systemic metabolic disorder (SMD)
This review reveals that Morinda citrifolia L., with bioactive components, alleviates systemic metabolic disorders through multiple mechanisms, provides in vitro / in vivo evidence, and highlights its potential as a natural intervention for SMD.
- 8 December 2025
- Published by Royal Society of Chemistry (RSC) in Food & Function
- Vol. 16 (24) , 9300-9343
Morinda citrifolia L. (noni) and its potential in the management of systemic metabolic disorder (SMD)
This review reveals that Morinda citrifolia L., with bioactive components, alleviates systemic metabolic disorders through multiple mechanisms, provides in vitro / in vivo evidence, and highlights its potential as a natural intervention for SMD.
- 17 May 2025
- Published by Elsevier in Ageing Research Reviews
- Vol. 109, 102776
Crosstalk between kidney and bones: New perspective for modulating osteoporosis
- 17 May 2025
- Published by Elsevier in Ageing Research Reviews
- Vol. 109, 102776
Crosstalk between kidney and bones: New perspective for modulating osteoporosis
- 6 April 2025
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 347, 119727
Decoding the pharmacodynamics of Fufang Tongye Shaoshang You: A promising ethnomedicine for diabetic ulcer healing
- 6 April 2025
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 347, 119727
Decoding the pharmacodynamics of Fufang Tongye Shaoshang You: A promising ethnomedicine for diabetic ulcer healing
- Open Access
- 1 March 2024
- Published by MDPI AG in Pharmaceuticals
- Vol. 17 (3) , 325
Screening for Active Compounds of Acorus calamus against SARS-CoV-2 Viral Protease and Mechanism Prediction
COVID-19, caused by SARS-CoV-2, has emerged as the most destructive emerging infectious disease of the 21st century. Vaccination is an effective method to combat viral diseases. However, due to the constant mutation of the virus, new variants may weaken the efficacy of vaccines. In the current field of new coronavirus research, viral protease inhibitors have emerged as a highly regarded therapeutic strategy. Nevertheless, existing viral protease inhibitors do not fully meet the therapeutic needs. Therefore, this paper turned to traditional Chinese medicine to explore new active compounds. This study focused on 24 isolated compounds from Acorus calamus L. and identified 8 active components that exhibited significant inhibitory effects on SARS-CoV-2 PLpro. Among these, the compound 1R,5R,7S-guaiane-4R,10R-diol-6-one demonstrated the best inhibitory activity with IC50 values of 0.386 ± 0.118 μM. Additionally, menecubebane B and neo-acorane A exhibited inhibitory activity against both Mpro and PLpro proteases, indicating their potential as dual-target inhibitors. The molecular docking results confirmed the stable conformations of these compounds with the key targets and their good activity. ADMET and Lipinski’s rule analyses revealed that all the small molecule ligands possessed excellent oral absorption properties. This study provides an experimental foundation for the discovery of promising antiviral lead compounds.
- 1 March 2024
- Published by MDPI AG in Pharmaceuticals
- Vol. 17 (3) , 325
Open AccessScreening for Active Compounds of Acorus calamus against SARS-CoV-2 Viral Protease and Mechanism Prediction
COVID-19, caused by SARS-CoV-2, has emerged as the most destructive emerging infectious disease of the 21st century. Vaccination is an effective method to combat viral diseases. However, due to the constant mutation of the virus, new variants may weaken the efficacy of vaccines. In the current field of new coronavirus research, viral protease inhibitors have emerged as a highly regarded therapeutic strategy. Nevertheless, existing viral protease inhibitors do not fully meet the therapeutic needs. Therefore, this paper turned to traditional Chinese medicine to explore new active compounds. This study focused on 24 isolated compounds from Acorus calamus L. and identified 8 active components that exhibited significant inhibitory effects on SARS-CoV-2 PLpro. Among these, the compound 1R,5R,7S-guaiane-4R,10R-diol-6-one demonstrated the best inhibitory activity with IC50 values of 0.386 ± 0.118 μM. Additionally, menecubebane B and neo-acorane A exhibited inhibitory activity against both Mpro and PLpro proteases, indicating their potential as dual-target inhibitors. The molecular docking results confirmed the stable conformations of these compounds with the key targets and their good activity. ADMET and Lipinski’s rule analyses revealed that all the small molecule ligands possessed excellent oral absorption properties. This study provides an experimental foundation for the discovery of promising antiviral lead compounds.